Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Irene Wapnir"'
Autor:
Takuya Osada, Erica Browning, Erika Crosby, Hiroshi Nagata, Melinda Telli, Chaitanya Acharya, Irene Wapnir, Kaitlin Zablotsky, Reneta Hermiz, Lauren Svenson, Donna Bannavong, Kellie Malloy, David Canton, Christopher Twitty, Herbert Lyerly
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/c561f28698a24467bc51a278cfc482d2
Autor:
Rachel L. Yang, Irene Wapnir
Publikováno v:
Health Equity, Vol 2, Iss 1, Pp 109-116 (2018)
Purpose: Disparities in surgical breast cancer care have been documented for racial and ethnic minorities. On average, these minorities are less likely to utilize National Cancer Institute (NCI)-designated cancer centers and travel shorter distances
Externí odkaz:
https://doaj.org/article/a5fbefdecd454f438a5820f269530234
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 1, p 92 (2021)
While surgical options exist to treat lymphedema after axillary lymph node dissection (ALND), the lymphatic microsurgical preventive healing approach (LYMPHA) has been introduced as a preventive measure performed during the primary surgery, thus avoi
Externí odkaz:
https://doaj.org/article/8c31bf9e32334aa3afca6967a820983f
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 5, Iss 9S, Pp 87-87 (2017)
Externí odkaz:
https://doaj.org/article/ee3663fa577545cea0afb5d87a249593
Publikováno v:
Molecular Imaging, Vol 5 (2006)
Optical imaging has made it possible to monitor response to anticancer therapies in tumor xenografts. The concept of treating breast cancers with 131 I is predicated on the expression of the Na + /I − symporter (NIS) in many tumors and uptake of I
Externí odkaz:
https://doaj.org/article/78badc48ed3b41e7a2cb78a2c07c33d2
Autor:
Lauren Daly, Jacqueline Tsai, Kim Stone, Irene Wapnir, Mardi Karin, Derrick Wan, Arash Momeni
Publikováno v:
Microsurgery.
Autor:
Erika J. Crosby, H. Kim Lyerly, Takuya Osada, Christopher G. Twitty, David A. Canton, Kellie Malloy Foerter, Jendy Sell, Kim Jaffe, Donna Bannavong, Lauren Svenson, Reneta Hermiz, Erica Browning, Robert H. Pierce, Mai Hope Le, Carmen Ballesteros-Merino, Shawn M. Jensen, Carlo B. Bifulco, Bernard A. Fox, Kaitlin Zablotsky, Chaitanya R. Acharya, Irene Wapnir, Hiroshi Nagata, Melinda L. Telli
Figure S5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44a596ca06ec554d854aa13d403d5a24
https://doi.org/10.1158/1078-0432.22484048
https://doi.org/10.1158/1078-0432.22484048
Autor:
Erika J. Crosby, H. Kim Lyerly, Takuya Osada, Christopher G. Twitty, David A. Canton, Kellie Malloy Foerter, Jendy Sell, Kim Jaffe, Donna Bannavong, Lauren Svenson, Reneta Hermiz, Erica Browning, Robert H. Pierce, Mai Hope Le, Carmen Ballesteros-Merino, Shawn M. Jensen, Carlo B. Bifulco, Bernard A. Fox, Kaitlin Zablotsky, Chaitanya R. Acharya, Irene Wapnir, Hiroshi Nagata, Melinda L. Telli
Table S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16ca7169c9f34582371ebebd076f3eb7
https://doi.org/10.1158/1078-0432.22484039
https://doi.org/10.1158/1078-0432.22484039
Autor:
Erika J. Crosby, H. Kim Lyerly, Takuya Osada, Christopher G. Twitty, David A. Canton, Kellie Malloy Foerter, Jendy Sell, Kim Jaffe, Donna Bannavong, Lauren Svenson, Reneta Hermiz, Erica Browning, Robert H. Pierce, Mai Hope Le, Carmen Ballesteros-Merino, Shawn M. Jensen, Carlo B. Bifulco, Bernard A. Fox, Kaitlin Zablotsky, Chaitanya R. Acharya, Irene Wapnir, Hiroshi Nagata, Melinda L. Telli
Supplementary methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b225ca75afa3d921ee14dfdf27630e8
https://doi.org/10.1158/1078-0432.22484042
https://doi.org/10.1158/1078-0432.22484042
Autor:
Erika J. Crosby, H. Kim Lyerly, Takuya Osada, Christopher G. Twitty, David A. Canton, Kellie Malloy Foerter, Jendy Sell, Kim Jaffe, Donna Bannavong, Lauren Svenson, Reneta Hermiz, Erica Browning, Robert H. Pierce, Mai Hope Le, Carmen Ballesteros-Merino, Shawn M. Jensen, Carlo B. Bifulco, Bernard A. Fox, Kaitlin Zablotsky, Chaitanya R. Acharya, Irene Wapnir, Hiroshi Nagata, Melinda L. Telli
Purpose:Triple-negative breast cancer (TNBC) is an aggressive disease with limited therapeutic options. Antibodies targeting programmed cell death protein 1 (PD-1)/PD-1 ligand 1 (PD-L1) have entered the therapeutic landscape in TNBC, but only a minor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e551cda28c1fd25f0ef23972aa309b8
https://doi.org/10.1158/1078-0432.c.6531311.v1
https://doi.org/10.1158/1078-0432.c.6531311.v1